SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
Authors
Keywords
Prostate cancer, SPOP, ATF2, Ubiquitination, Proteasomal degradation
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-11
DOI
10.1186/s13046-018-0809-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
- (2017) Xiangpeng Dai et al. NATURE MEDICINE
- Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation
- (2017) Pingzhao Zhang et al. NATURE MEDICINE
- Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
- (2017) Hana Janouskova et al. NATURE MEDICINE
- ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma
- (2016) Deng-shuang Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Multiple Weak Linear Motifs Enhance Recruitment and Processivity in SPOP-Mediated Substrate Ubiquitination
- (2016) Wendy K. Pierce et al. JOURNAL OF MOLECULAR BIOLOGY
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation
- (2015) Jian An et al. MOLECULAR CELL
- SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression
- (2015) Wenjian Gan et al. MOLECULAR CELL
- Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma
- (2015) ZHENYU YOU et al. Oncology Letters
- SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase
- (2015) Hengrui Zhu et al. Cell Reports
- All-Trans Retinoic Acid Induces TGF-β2 in Intestinal Epithelial Cells via RhoA- and p38α MAPK-Mediated Activation of the Transcription Factor ATF2
- (2015) Kopperuncholan Namachivayam et al. PLoS One
- SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts
- (2015) Mirjam Blattner et al. NEOPLASIA
- Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
- (2014) C. Geng et al. CANCER RESEARCH
- Destruction of DDIT3/CHOP Protein by Wild-Type SPOP but Not Prostate Cancer-Associated Mutants
- (2014) Pingzhao Zhang et al. HUMAN MUTATION
- Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
- (2014) Jian An et al. Cell Reports
- The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications
- (2013) Pascal Genschik et al. EMBO JOURNAL
- TAK1 regulates SOX9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages
- (2013) Lin Gao et al. JOURNAL OF CELL SCIENCE
- Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover
- (2013) C. Geng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PKCε Promotes Oncogenic Functions of ATF2 in the Nucleus while Blocking Its Apoptotic Function at Mitochondria
- (2012) Eric Lau et al. CELL
- ATF2 – at the crossroad of nuclear and cytosolic functions
- (2012) Eric Lau et al. JOURNAL OF CELL SCIENCE
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- A Role for ATF2 in Regulating MITF and Melanoma Development
- (2010) Meera Shah et al. PLoS Genetics
- Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin Ligases
- (2009) Min Zhuang et al. MOLECULAR CELL
- The role of ATF-2 in oncogenesis
- (2008) Spiros A. Vlahopoulos et al. BIOESSAYS
- Suppressor role of activating transcription factor 2 (ATF2) in skin cancer
- (2008) A. Bhoumik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started